H. Akil, A. Perraud, C. Mélin, M. Jauberteau, and M. Mathonnet, Fine-Tuning Roles of Endogenous Brain-Derived Neurotrophic Factor, TrkB and Sortilin in Colorectal Cancer Cell Survival, PLoS ONE, vol.124, issue.9, p.25097, 2011.
DOI : 10.1371/journal.pone.0025097.t003

URL : https://hal.archives-ouvertes.fr/hal-00873136

A. Alizadeh, M. Eisen, R. Davis, C. Ma, I. Lossos et al., Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling, Nature, vol.303, issue.6769, pp.503-511, 2000.
DOI : 10.1038/35000501

E. Arranz, M. Robledo, B. Martínez, J. Gallego, A. Román et al., Incidence of homogeneously staining regions in non-Hodgkin lymphomas, Cancer Genetics and Cytogenetics, vol.87, issue.1, pp.1-3, 1996.
DOI : 10.1016/0165-4608(95)00230-8

A. Baldwin, Control of oncogenesis and cancer therapy resistance by the transcription factor NF-??B, Journal of Clinical Investigation, vol.107, issue.3, pp.241-246, 2001.
DOI : 10.1172/JCI11991

P. Barker, High Affinity Not in the Vicinity?, Neuron, vol.53, issue.1, pp.1-4, 2007.
DOI : 10.1016/j.neuron.2006.12.018

C. Bellanger, L. Dubanet, M. Lise, A. Fauchais, D. Bordessoule et al., Endogenous Neurotrophins and Trk Signaling in Diffuse Large B Cell Lymphoma Cell Lines Are Involved in Sensitivity to Rituximab-Induced Apoptosis, PLoS ONE, vol.6, issue.11, p.27213, 2011.
DOI : 10.1371/journal.pone.0027213.t001

URL : https://hal.archives-ouvertes.fr/hal-00873135

G. Chaitanya, A. Steven, and P. Babu, PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration, Cell Communication and Signaling, vol.8, issue.1, p.31, 2010.
DOI : 10.1186/1478-811X-8-31

R. Davis, K. Brown, U. Siebenlist, and L. Staudt, Constitutive Nuclear Factor ??B Activity Is Required for Survival of Activated B Cell???like Diffuse Large B Cell Lymphoma Cells, The Journal of Experimental Medicine, vol.15, issue.12, pp.1861-1874, 2001.
DOI : 10.1016/S0960-894X(98)00029-8

D. Santi, L. Annunziata, P. Sessa, E. Bramanti, and P. , Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis, Journal of the Neurological Sciences, vol.287, issue.1-2, pp.17-26, 2009.
DOI : 10.1016/j.jns.2009.08.057

A. Fauchais, F. Lalloué, M. Lise, A. Boumediene, J. Preud-'homme et al., Role of Endogenous Brain-Derived Neurotrophic Factor and Sortilin in B Cell Survival, The Journal of Immunology, vol.181, issue.5, pp.3027-3038, 2008.
DOI : 10.4049/jimmunol.181.5.3027

URL : https://hal.archives-ouvertes.fr/hal-00453223

P. Forsyth, N. Krishna, S. Lawn, J. Valadez, X. Qu et al., neurotrophin receptor cleavage by a-and g-secretases is required for neurotrophinmediated proliferation of brain tumor-initiating cells, J Biol Chem, vol.289, pp.75-8067, 2014.

D. Gratzinger, S. Zhao, R. Marinelli, A. Kapp, R. Tibshirani et al., Microvessel Density and Expression of Vascular Endothelial Growth Factor and Its Receptors in Diffuse Large B-Cell Lymphoma Subtypes, The American Journal of Pathology, vol.170, issue.4, pp.1362-1369, 2007.
DOI : 10.2353/ajpath.2007.060901

D. Gratzinger, S. Zhao, R. Tibshirani, E. Hsi, C. Hans et al., Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy, Laboratory Investigation, vol.6, issue.1, pp.38-47, 2008.
DOI : 10.1016/j.ejca.2006.09.015

D. Gratzinger, R. Advani, S. Zhao, N. Talreja, R. Tibshirani et al., Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP), British Journal of Haematology, vol.324, issue.2, pp.235-244, 2010.
DOI : 10.1111/j.1365-2141.2009.07942.x

C. Hans, D. Weisenburger, T. Greiner, R. Gascoyne, J. Delabie et al., Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray, Blood, vol.103, issue.1, pp.275-282, 2004.
DOI : 10.1182/blood-2003-05-1545

K. Heese, N. Inoue, and T. Sawada, NF-kappaB regulates B-cell-derived nerve growth factor expression, Cell Mol Immunol, vol.3, pp.63-66, 2006.

J. Karar and A. Maity, PI3K/AKT/mTOR Pathway in Angiogenesis, Frontiers in Molecular Neuroscience, vol.4, p.51, 2011.
DOI : 10.3389/fnmol.2011.00051

N. Kawamura, K. Kawamura, M. Manabe, and T. Tanaka, Inhibition of Brain-Derived Neurotrophic Factor/Tyrosine Kinase B Signaling Suppresses Choriocarcinoma Cell Growth, Endocrinology, vol.151, issue.7, pp.3006-3014, 2010.
DOI : 10.1210/en.2009-1378

L. Lam, R. Davis, J. Pierce, M. Hepperle, Y. Xu et al., Small molecule inhibitors of IkB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling, Clin Cancer Res, vol.11, pp.28-40, 2005.

G. Lenz, G. Wright, S. Dave, X. W. Powell, J. Zhao et al., Stromal Gene Signatures in Large-B-Cell Lymphomas, Stromal gene signatures in large-B-cell lymphomas. Lymphoma/Leukemia Molecular Profiling Project, pp.2313-2323, 2008.
DOI : 10.1056/NEJMoa0802885

URL : http://digitalcommons.unmc.edu/cgi/viewcontent.cgi?article=1031&context=com_pathmicro_articles

K. Michaelsen, M. Zagrebelsky, J. Berndt-huch, M. Polack, A. Buschler et al., Neurotrophin receptors TrkB.T1 and p75NTR cooperate in modulating both functional and structural plasticity in mature hippocampal neurons, European Journal of Neuroscience, vol.25, issue.11, pp.1854-1865, 2010.
DOI : 10.1111/j.1460-9568.2010.07460.x

K. Nakamura, K. Martin, J. Jackson, K. Beppu, C. Woo et al., Brain-Derived Neurotrophic Factor Activation of TrkB Induces Vascular Endothelial Growth Factor Expression via Hypoxia-Inducible Factor-1?? in Neuroblastoma Cells, Cancer Research, vol.66, issue.8, pp.4249-4255, 2006.
DOI : 10.1158/0008-5472.CAN-05-2789

K. Nakamura, F. Tan, Z. Li, and C. Thiele, NGF activation of TrkA induces vascular endothelial growth factor expression via induction of hypoxia-inducible factor-1??, Molecular and Cellular Neuroscience, vol.46, issue.2, pp.498-506, 2011.
DOI : 10.1016/j.mcn.2010.12.002

A. Nykjaer, R. Lee, K. Teng, P. Jansen, P. Madsen et al., Sortilin is essential for proNGF-induced neuronal cell death, Nature, vol.427, issue.6977, pp.843-848, 2004.
DOI : 10.1038/nature02319

Y. Okugawa, K. Tanaka, Y. Inoue, M. Kawamura, A. Kawamoto et al., Brain-derived neurotrophic factor/tropomyosin-related kinase B pathway in gastric cancer, British Journal of Cancer, vol.65, issue.1, pp.121-130, 2013.
DOI : 10.1007/s11033-008-9299-z

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3553513

Q. Qiao, Y. Nozaki, K. Sakoe, N. Komatsu, and K. Kirito, NF-??B mediates aberrant activation of HIF-1 in malignant lymphoma, Experimental Hematology, vol.38, issue.12, pp.1199-1208, 2010.
DOI : 10.1016/j.exphem.2010.08.007

B. Reichardt, Neurotrophin-regulated signalling pathways, Philosophical Transactions of the Royal Society B: Biological Sciences, vol.20, issue.5, pp.1545-1564, 2006.
DOI : 10.1128/MCB.20.5.1507-1514.2000

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1664664

A. Rezvani and D. Maloney, Rituximab resistance, Best Practice & Research Clinical Haematology, vol.24, issue.2, pp.203-216, 2011.
DOI : 10.1016/j.beha.2011.02.009

A. Rosenwald, G. Wright, W. Chan, J. Connors, E. Campo et al., The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma, Lymphoma/Leukemia Molecular Profiling Project, pp.1937-1947, 2002.
DOI : 10.1056/NEJMoa012914

J. Seymour, M. Pfreundschuh, . Trne-?ny´m?ny´?ny´m, L. Sehn, J. Catalano et al., R-CHOP with or without bevacizumab in patients with previously untreated diffuse large B-cell lymphoma: final MAIN study outcomes, Haematologica, vol.99, issue.8, pp.1343-1349, 2014.
DOI : 10.3324/haematol.2013.100818

L. Sniderhan, T. Garcia-bates, M. Burgart, S. Bernstein, R. Phipps et al., Neurotrophin signaling through tropomyosin receptor kinases contributes to survival and proliferation of non-Hodgkin lymphoma, Experimental Hematology, vol.37, issue.11, pp.1295-1309, 2009.
DOI : 10.1016/j.exphem.2009.08.005

E. Suzuki, K. Umezawa, and B. Bonavida, Rituximab inhibits the constitutively activated PI3K-Akt pathway in B-NHL cell lines: involvement in chemosensitization to drug-induced apoptosis, Oncogene, vol.35, issue.42, pp.6184-6193, 2007.
DOI : 10.1038/onc.2016.207

S. Swerdlow, E. Campo, N. Harris, E. Jaffe, S. Pileri et al., WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 2008.

K. Teng, F. S. Kim, T. Hempstead, and B. , Understanding proneurotrophin actions: Recent advances and challenges, Developmental Neurobiology, vol.6, pp.350-359, 2010.
DOI : 10.1002/dneu.20768

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063094

C. Thiele, Z. Li, and A. Mckee, On Trk--The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology, Clinical Cancer Research, vol.15, issue.19, pp.5962-5967, 2009.
DOI : 10.1158/1078-0432.CCR-08-0651

D. Troutaud, B. Petit, C. Bellanger, B. Marin, M. Gourin-chaury et al., Prognostic Significance of BAD and AIF Apoptotic Pathways in Diffuse Large B-Cell Lymphoma, Clinical Lymphoma Myeloma and Leukemia, vol.10, issue.2, pp.118-124, 2010.
DOI : 10.3816/CLML.2010.n.016

URL : https://hal.archives-ouvertes.fr/hal-00597660

E. Vanhecke, E. Adriaenssens, S. Verbeke, S. Meignan, E. Germain et al., Brain-Derived Neurotrophic Factor and Neurotrophin-4/5 Are Expressed in Breast Cancer and Can Be Targeted to Inhibit Tumor Cell Survival, Clinical Cancer Research, vol.17, issue.7, pp.1741-1752, 2011.
DOI : 10.1158/1078-0432.CCR-10-1890

J. Vega, O. García-suárez, J. Hannestad, M. Pérez-pérez, and A. Germanà, Neurotrophins and the immune system, Journal of Anatomy, vol.203, issue.1, pp.1-19, 2003.
DOI : 10.1046/j.1469-7580.2003.00203.x

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1571144

Y. Wang, D. Fei, M. Vanderlaan, and A. Song, Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro, Angiogenesis, vol.10, issue.5, pp.335-345, 2004.
DOI : 10.1007/s10456-004-8272-2

T. Wehrman, X. He, B. Raab, A. Dukipatti, H. Blau et al., Structural and Mechanistic Insights into Nerve Growth Factor Interactions with the TrkA and p75 Receptors, Neuron, vol.53, issue.1, pp.25-38, 2007.
DOI : 10.1016/j.neuron.2006.09.034

G. Weiner, Rituximab: Mechanism of Action, Seminars in Hematology, vol.47, issue.2, pp.115-123, 2010.
DOI : 10.1053/j.seminhematol.2010.01.011

G. Wright, B. Tan, A. Rosenwald, E. Hurt, A. Wiestner et al., A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma, Proceedings of the National Academy of Sciences, vol.97, issue.26, pp.9991-9996, 2003.
DOI : 10.1073/pnas.211566398